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Smnuary Diagnosis of hereditary non-polyposis colorectal cancer (HNPCC) is currently based on
phenotypical analysis of an expanded pedigree. Diagnostic guidelines ('Amsterdam criteria') proposed by the
International Collaborative Group on HNPCC are often too stringent for use with small families. There is
also the possibility of false-positive diagnosis in large pedigrees that may contain chance clusters of tumours.
This study was conducted to determine the effect of family size on the probability of diagnosing HNPCC
according to the Amsterdam criteria. A total of 1052 patients with colorectal cancer were classified as HNPCC
or non-HNPCC according to the Amsterdam criteria. Associations between this diagnosis and the size of the
first-degree pedigree were evaluated in logistic regression and linear discriminant analyses. Logistic regression
showed a significant association for family size with the Amsterdam-criteria-based HNPCC diagnosis. Linear
discriminant analysis showed that HNPCC diagnosis was most likely to occur when first-degree pedigrees
contained more than seven relatives. Failure to consider family size in phenotypic diagnosis of HNPCC can
lead to both under- and overestimation of the frequency of this disease. Small pedigrees must be expanded to
reliably exclude HNPCC. Positive diagnoses based on assessment of eight or more first-degree relatives should
be supported by other clinical features.
Keywords: hereditary non-polyposis
discriminant analysis
colorectal cancer; phenotypic analysis: family size: logistic regression,
Hereditary non-polyposis colorectal cancer (HNPCC) is a
genetic, autosomal dominant disease charactenrsed by early
onset (around 40-45 years ofage) colorectal tumours, partic-
ularly in the proximal colon (70%), and an excess ofmultiple
primaries (synchronous and/or metachronous) (Lynch et al.,
1993). The frequency of endometnril, gastnrc, ovarian and
unnary tract tumours is also increased in the vast majority of
HNPCC families (Lynch II syndrome or cancer family synd-
rome) (Lynch et al., 1988; Watson and Lynch, 1993).
Although important advances have recently been made
towards the development of a genetic marker for HNPCC
(Fishel et al., 1993; Bronner et al., 1994; Nicolaides et al.,
1994; Papadopoulos et al., 1994), phenotypical pedigree
analysis remains the primary approach to identifying this
syndrome.
Using this approdch, various groups have attempted to
estimate the frequency of Lynch syndrome and their results
indicate that HNPCC accounts for 0.5-6% of all cases of
colorectal cancer (Mecklin, 1987; Vasen et al., 1989; Kee and
Collins, 1991; Stephenson et al., 1991; Aaltonen et al., 1994).
The disparity of these results can be attributed in part to the
subtle differences in classification criteria used in these
studies, and the need for uniformity (particularly in multicen-
tre studies) led to the establishment, in 1990, of the so-called
'Amsterdam criteria' by the International Collaborative
Group on HNPCC (ICG-HNPCC) (Vasen et al., 1991a).
According to this panel, an HNPCC pedigree must meet all
of the following three criteria:
(1) three or more family members with histologically
verified colon cancer, one of whom is a first-degree
relative of the other two;
(2) at least two consecutive generations affected;
(3) at least one of the cases of colorectal cancer has been
diagnosed before the age of 50.
The use of these criteria in normal clinical practice, however,
has revealed a number of shortcomings in both their sen-
sitivity and specificity. One of the criticisms that has been
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advanced is that these criteria fail to consider extracolonic
malignancies as a clinical manifestation of HNPCC (Vasen et
al., 1991b). In addition, the probability of finding three cases
of colon cancer within the small families that are typical of
most Western countnres is fairly limited, and pedigree expan-
sion to second- and third-degree relatives is almost always
necessary. However, because of the high incidence of colon
tumours, evaluation and verification of expanded pedigree
data for all colon cancer patients can represent an enormous
amount of work. This approach also requires collaboration
by the proband and his/her family and knowledge of distant
relatives, which may not be available, particularly in count-
ries in which family ties have become attenuated. On the
other hand, when large pedigrees are evaluated there is
always a risk of false-positive diagnosis based on chance
aggregation of tumours or the effects of common
environmental risk factors, such as diet (Khoury et al.,
1988).
We have, therefore, developed a stepwise approach for
identification of families at risk of HNPCC, which involves
an initial assessment of the first-degree pedigree for the
presence of six clinical characteristics associated with
hereditary cancer syndromes (Ponz de Leon et al., 1993a;
Benatti et al., 1993; Percesepe et al., 1994) (Table 1). When
three or more of these characteristics are present. the
pedigree is expanded to include second- and third-degree
relatives (if possible) and re-evaluated according to the Ams-
terdam criteria. In a previous study to assess the reliability of
this method, only a very small percentage of the first-degree
pedigrees with less than three of the elements listed in Table I
satisfied the Amsterdam criteria after expansion to second-
and third-degrees (Ponz de Leon et al., 1993a).
The purpose of the present study was to ascertain whether
family size does indeed influence the diagnosis of HNPCC
according to the Amsterdam criteria. Because of the stepwise
approach that we use, expanded pedigrees are available only
for those cases in which there is already a suspicion of Lynch
syndrome. For this reason, the effect of the first-degree
pedigree size was analysed, even though the diagnosis of
HNPCC is usually based on the evaluation of extended
pedigrees.Materals and methods
Patients
As previously descnrbed (Percesepe et al., 1994), our database
consists of two sources: (1) the Colorectal Cancer Registry of
the University of Modena, a population-based registry, which
records all colorectal malignancies diagnosed in patients
residing in Health Care District 16 of the Fmilia-Romagna
Region of Italy (including the city of Modena and ten
smaller communities); (2) medical records for all consecutive
cases of colorectal cancer referred to the Departments of
Surgery and Internal Medicine of the Catholic University of
Rome. These sources provided a total of 1180 patients with
colorectal tumours.
Patients with familial adenomatous polyposis, inflam-
matory bowel disease, carcinoid tumours or anal carcinoma,
as well as those individuals whose family histories could not
be adequately ascertained, were excluded from the study.
Thus, a total of 1052 unrelated patients with colorectal
cancer were selected as probands: 860 (89%) of the 966
registered in the University of Modena Registry between
1984 and 1990 and 192 (90%) of the 214 referred to the
Catholic University between April 1992 and April 1994.
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154 considered non-HNPCC (total number of non-HNPCC
patients: 1020).
The age of the proband at diagnosis and the number of
assessable first-degree relatives were recorded. Because the
development of colorectal cancer is highly unlikely before the
age of 25, healthy relatives under this age were not con-
sidered in calculating the first-degree pedigree size.
Statistical analyses were carried out on microcomputers
with SPSS (SPSS, Chicago, IL, USA) and BMDP (BMDP.
Berkeley. CA, USA) software. Associations between the
Amsterdam-criteria-based diagnosis (dichotomous dependent
vanrable) and the continuous independent variables, first-
degree pedigree size and proband age at diagnosis, were
evaluated in logistic regression analysis (Engelman. 1990) and
expressed as odds ratios (OR) with 95% confidence intervals
(CI). Since younger probands might be expected to have
smaller pedigrees, and early onset is included among the
Amsterdam criteria, the model was adjusted for the poten-
tially confounding effect of age of onset.
Linear discriminant analysis (Jemlrich and Sampson, 1990)
was used to calculate threshold values for first-degree
pedigree size above which an Amsterdam criteria-based
HNPCC diagnosis was most likely to be made and to assess
the specificity and sensitivity of these diagnosies according to
the size of the pedigree.
Stud) design and data analysis
These 1052 patients and/or their first-degree relatives were
personally interviewed, and detailed first-degree pedigrees
were drawn. Neoplastic mortality and morbidity were
verified by clinical and pathological reports and/or death
certificates, as previously described (Ponz de Leon et al.,
1993a; Benatti et al., 1993). Cancer verification rate in
relatives was 59%. When less than three of the characteristics
listed in Table I were present in the pedigree. the proband
was classified as non-HNPCC (866 cases). Those pedigrees
that met three or more of the criteria in Table I were
expanded to second and third degrees and re-evaluated ac-
cording to the Amsterdam criteria. This second phase of
assessment yielded 32 probands classified as HNPCC and
Table I Phenotypic features suggestive of genetically based








Mucinous carcinoma of the
large bowel
Diagnosis of colorectal cancer or
early-onset cancer of the
stomach, endometrium, larynx.
kidneys or urinary tract in
one of the proband's parents
or offspring
Diagnosis of cancer (at any site)
in at least 50% of the
patient's siblings or members
of the nuclear family
Before the age of 50
Proband: primary tumour of the
caecum, ascending or
transverse colon or at one of
the colonic flexures
Proband: multiple primanies in
the large bowel or in another
organ
Proband: colorectal tumour with
this histotype
Results
Application of the Amsterdam criteria to the extended
pedigrees revealed that 32 families (3.0% of all those
examined) could be considered HNPCC. Figure 1 shows the
frequency distribution (per cent) of HNPCC and non-
HNPCC probands according to the size of the first-degree
pedigree. Compared with that for the latter group, the curve
for the HNPCC group displays a shift to the right indicating
a greater tendency toward larger pedigrees. Table II shows
the results of logistic regression analysis, which revealed sig-
nificant associations between the Amsterdam-criteria-based
diagnosis and both pedigree size and proband age at diag-
nosis. The odds ratios show that the probability of a positive
diagnosis increases as the number of first-degree relatives
increases and as the proband's age at diagnosis decreases.
These results did not change when colorectal cancer cases
from the University of Rome, which were not population
based, were excluded from the analysis (data not shown).
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Figwe 1 Frequency distnrbution (per cent) of the two senres.
according to their first-degree pedigree size. U, HNPCC; 0.
non-HNPCC.
Table H First-degree pedigree size and age at diagnosis (group means ± 1 standard
deviation) and their associations with HNPCC diagnosis
HNPCC Non-HNPCC Odds ratio for
(n = 32) (n = 1020) 1 unit increase 95% CI
First-degree 7.9 2.9 6.9 2.9 1.24 1.10- 1.40
pedigree size
Age at diagnosis 57.5 ± 12.6 67.2 ± 11.2 0.92 0.89-0.95
The odds ratios and 95% confidence intervals (CI) were calculated with a
multivariate logistic regression model.Family size and HC diagn-is
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HNPCC diagnosis was most likely when first-degree
pedigrees contained more than seven relatives. Considenrng
family size as the unique discriminant factor. the percentage
of families predicted as HNPCC. above the threshold value
of seven relatives, was 62.5% for the Amsterdam-criteria-
based HNPCC diagnosis. whereas it was only 38.2% for
those classified as non-HNPCC. Thus family size resulted as
a powerful discriminant in our population.
Discussion
Our decision to assess the effect of the size of the first-degree
pedigree on the probability of reaching a positive diagnosis
of HNPCC according to the Amsterdam criteria was based
on our experiences in large urban medical centres in Italy.
which have an incidence rate of 50-60 colorectal malignan-
cies per year (Ponz de Leon et al.. 1993b). Analysis of
extended pedigrees in these settings requires a great deal of
work on the part of the physician and families. We have thus
developed a stepwise approach for the identification of
HNPCC families that begins with an evaluation of the first-
degree pedigree. This initial screening has proved to be ext-
remely reliable in excluding the need for further pedigree
expansion. In a previous study. 60 first-degree pedigrees that
failed to meet at least three of the criteria listed in Table I
were subsequently expanded and evaluated according to the
Amsterdam criteria: only three (5%) of these extended
families were able to satisfy the latter definition (Ponz de
Leon et al., 1993a). In light of these findings, the non-
HNPCC diagnoses made on the basis of our initial assess-
ment in 866 probands should not be considered different
from those made after expansion in the other 154 non-
HNPCC cases. Pedigree expansion is warranted, however,
when three or more of our criteria are met by the first-degree
family. and all 32 HNPCC probands were classified accord-
ing to assessment of the Amsterdam criteria in expanded
pedigrees.
As expected. the results of our analysis indicated that
family size plays an important role in determining the out-
come of the pedigree assessment: the relative risk of a
positive diagnosis increases by 24% with each additional
first-degree relative. This association was not dependent on
the age of the proband at diagnosis. The latter variable was
also significantly associated with the HNPCC diagnosis, the
risk of a positive diagnosis increasing by approximateiy 8%
with each yearly decrease in the age at diagnosis. The results
of our linear discriminant analysis suggest that a negative
diagnosis based on evaluation of a first-degree pedigree con-
taining fewer than eight members might well be the result of
inadequate data for analysis. In most cases of this type,
particularly those in which the number of first-degree
relatives is significantly lower than eight. expansion of the
pedigree to second- and third-degree relatives is probably
advisable to reliably exclude the possibility of HNPCC. In
contrast. the possibility of false-positive diagnosis should be
considered when it is based on evaluation of more than eight
first-degree relatives. Chance aggregation, an effect of com-
mon environmental risk factors or other forms of genetic
susceptibility might be suspected. for example in positive
families of this type with no clear pattern of autosomal
dominant transmission, a predominance of left colon
tumours or a high mean age of tumour onset. Based on the
surveillance. epidemiology and end results (SEER) data.
Lynch et al. (1993) have recently estimated that. as a random
event, the probability that an affected proband under 50 with
12 relatives will meet the Amsterdam criteria is approx-
imately three times higher than that for a proband of the
same age with only six first-degree relatives.
The frequency of Lynch syndrome observed in the popula-
tion we analysed (3%) is consistent with previous estimates
based on phenotypical analysis for other Western countries
(Mecklin. 1987; Vasen et al., 1989; Stephenson et al.. 1991).
even though the approaches used in these studies were sligh-
tly different from those proposed by the ICG-HNPCC. How-
ever, the fact that pedigree size was found to be an indepen-
dent predictor of the Amsterdam-cnrteria-based diagnosis
raises questions on the sensitivity as well as on the specificity
of all of these clinical criteria in identifying HNPCC families.
In a preliminary study by Leach et al. (1993). mutation of the
hMSH2 gene. which is considered to be one of the genes
responsible for HNPCC. was also observed in normal indi-
viduals with an allele frequency of 5%. This finding may
reflect gene polymorphism. It is also possible. however, that
this mutation is fairly frequent in the general population but
has a rather low penetrance. This would lead to genetic
susceptibility without familial clustering of tumours (Bodmer
et al., 1994), and. in this case. clinical criteria would be of
little or no help in reaching a diagnosis. Genetic testing is the
only reliable method for diagnosing these cases or those
caused by new mutations. It should be noted, however, that
the results of a genetic analysis are likely to be dependent. in
turn, on how the probands have been selected for study, and
whether a pedigree venrfication has been performed.
Large-scale screening for mutations of the known mis-
match repair genes does not seem at present feasible, since
the study of mutations is difficult, time consuming and possi-
ble only in a few laboratories. On the other hand, the
definitive characterisation of selected HNPCC families on a
biomolecular basis will allow further insights on fundamental
issues, such as the penetrance of gene mutations, their expres-
sivity (the spectrum of organs and tissues involved) and the
natural history of the disease.
In conclusion, we feel that clinical screening is still the
first-line approach to identification of HNPCC. In this set-
ting the criteria proposed by the ICG-HNPCC can be quite
useful, but their limitations must be kept in mind. The ICG
itself has recognised some of these shortcomings and has
pointed out that their criteria should not be intended as a
strict definition of Lynch syndrome. The effect of family size
on these diagnoses should be considered in interpreting the
outcome of pedigree studies, and other characteristics should
be assessed when doubts anrse. As birth rates in Western
countries continue to decline, clinical recognition of Lynch
syndrome in the general population may become increasingly
difficult.
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